Clinica Baviera SA
MAD:CBAV

Watchlist Manager
Clinica Baviera SA Logo
Clinica Baviera SA
MAD:CBAV
Watchlist
Price: 52.4 EUR 3.97% Market Closed
Market Cap: €854.6m

Wall Street
Price Targets

CBAV Price Targets Summary
Clinica Baviera SA

Wall Street analysts forecast CBAV stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CBAV is 61.2 EUR with a low forecast of 60.6 EUR and a high forecast of 63 EUR.

Lowest
Price Target
60.6 EUR
16% Upside
Average
Price Target
61.2 EUR
17% Upside
Highest
Price Target
63 EUR
20% Upside
Clinica Baviera SA Competitors:
Price Targets
NVT
nVent Electric PLC
10% Upside
FILA
FILA Fabbrica Italiana Lapis ed Affini SpA
51% Upside

Revenue
Forecast

8% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
8% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

For the last 13 years the compound annual growth rate for Clinica Baviera SA's revenue is 8%. The projected CAGR for the next 3 years is 11%.

Operating Income
Forecast

16% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
3%
Average Beat
16% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
3%
Average Beat

For the last 13 years the compound annual growth rate for Clinica Baviera SA's operating income is 16%. The projected CAGR for the next 3 years is 11%.

Net Income
Forecast

17% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
3%
Average Beat
17% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
3%
Average Beat

For the last 13 years the compound annual growth rate for Clinica Baviera SA's net income is 17%. The projected CAGR for the next 3 years is 11%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CBAV's stock price target?
Price Target
61.2 EUR

According to Wall Street analysts, the average 1-year price target for CBAV is 61.2 EUR with a low forecast of 60.6 EUR and a high forecast of 63 EUR.

What is Clinica Baviera SA's Revenue forecast?
Projected CAGR
11%

For the last 13 years the compound annual growth rate for Clinica Baviera SA's revenue is 8%. The projected CAGR for the next 3 years is 11%.

What is Clinica Baviera SA's Operating Income forecast?
Projected CAGR
11%

For the last 13 years the compound annual growth rate for Clinica Baviera SA's operating income is 16%. The projected CAGR for the next 3 years is 11%.

What is Clinica Baviera SA's Net Income forecast?
Projected CAGR
11%

For the last 13 years the compound annual growth rate for Clinica Baviera SA's net income is 17%. The projected CAGR for the next 3 years is 11%.

Back to Top